Table 3.
Results of meta-analysis comparison of TACE and hepatectomy
| Outcome | Studies numbers | TACE | Hepatectomy | OR/HR | P value | Heterogeneity | |||
|---|---|---|---|---|---|---|---|---|---|
| Χ2 | df | P | I2 | ||||||
| Over survival | 8 | 830 | 853 | 1.61 [1.23, 2.10] | 0.0005 | 29.55 | 7 | 0.0001 | 76% |
| PVTT subgroup | 6 | 754 | 790 | 1.50 [1.14, 1.98] | 0.004 | 22.99 | 6 | 0.0003 | 78% |
| HVTT/IVC subgroup | 2 | 76 | 63 | 2.39 [0.88, 6.49] | 0.09 | 3.46 | 1 | 0.06 | 71% |
| 1- year survival rate | 8 | 830 | 853 | 2.27 [1.26, 4.08] | 0.006 | 30.93 | 7 | <0.0001 | 77% |
| 3- year survival rate | 7 | 768 | 580 | 3.04 [2.17, 4.26] | <0.00001 | 9.84 | 6 | 0.13 | 39% |
| 5- year survival rate | 2 | 510 | 309 | 7.34 [0.79, 68.16] | 0.08 | 8.25 | 1 | 0.004 | 88% |
| Peri-operatvie mortality | 3 | 566 | 337 | 0.51 [0.17, 1.49] | 0.22 | 1.65 | 2 | 0.44 | 0% |
| Sensitivity analysis | |||||||||
| Over survival | 5 | 356 | 341 | 1.74 [1.45, 2.10] | <0.00001 | 5.97 | 4 | 0.2 | 33% |
| 1- year survival rate | 5 | 356 | 341 | 3.37 [1.91, 5.95] | <0.00001 | 8.01 | 4 | 0.09 | 50% |